Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach

Dorsey ER, Bloem BR. The Parkinson pandemic-a call to action. JAMA Neurol. 2018;75(1):9–10. https://doi.org/10.1001/jamaneurol.2017.3299.

Article  PubMed  Google Scholar 

Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, et al. Current and projected future economic burden of Parkinson’s disease in the U.S. NPJ Parkinsons Dis. 2020;6:15. https://doi.org/10.1038/s41531-020-0117-1.

Article  PubMed  PubMed Central  Google Scholar 

Niotis K, West AB, Saunders-Pullman R. Who to enroll in Parkinson disease prevention trials? The case for genetically at-risk cohorts. Neurol. 2022;99(7 Suppl 1):10–8. https://doi.org/10.1212/WNL.0000000000200812.

Article  Google Scholar 

Healy DG, Falchi M, O’Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol. 2008;7(7):583–90. https://doi.org/10.1016/S1474-4422(08)70117-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Shu L, Sun Q, Zhou X, Pan H, Guo J, et al. Integrated genetic analysis of racial differences of common GBA variants in Parkinson’s disease: a meta-analysis. Front Mol Neurosci. 2018;11:43. https://doi.org/10.3389/fnmol.2018.00043.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson’s disease in Ashkenazi Jews. N Engl J Med. 2004;351(19):1972–7. https://doi.org/10.1056/NEJMoa033277.

Article  CAS  PubMed  Google Scholar 

Neumann J, Bras J, Deas E, O’Sullivan SS, Parkkinen L, Lachmann RH, et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease. Brain. 2009;132(Pt 7):1783–94. https://doi.org/10.1093/brain/awp044.

Article  PubMed  PubMed Central  Google Scholar 

Petrucci S, Ginevrino M, Trezzi I, Monfrini E, Ricciardi L, Albanese A, et al. GBA-related Parkinson’s disease: dissection of genotype-phenotype correlates in a large Italian cohort. Mov Disord. 2020. https://doi.org/10.1002/mds.28195.

Article  PubMed  Google Scholar 

Liu G, Boot B, Locascio JJ, Jansen IE, Winder-Rhodes S, Eberly S, et al. Specifically neuropathic Gaucher’s mutations accelerate cognitive decline in Parkinson’s. Ann Neurol. 2016;80(5):674–85. https://doi.org/10.1002/ana.24781.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, et al. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Mov Disord. 2013;28(14):1966–71. https://doi.org/10.1002/mds.25647.

Article  CAS  PubMed  Google Scholar 

Saunders-Pullman R, Mirelman A, Alcalay RN, Wang C, Ortega RA, Raymond D, et al. Progression in the LRRK2-asssociated Parkinson disease population. JAMA Neurol. 2018;75(3):312–9. https://doi.org/10.1001/jamaneurol.2017.4019.

Article  PubMed  PubMed Central  Google Scholar 

Smith LJ, Lee CY, Menozzi E, Schapira AHV. Genetic variations in GBA1 and LRRK2 genes: biochemical and clinical consequences in Parkinson disease. Front Neurol. 2022;13:971252. https://doi.org/10.3389/fneur.2022.971252.

Article  PubMed  PubMed Central  Google Scholar 

Smith LJ, Bolsinger MM, Chau KY, Gegg ME, Schapira AHV. The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines. Hum Mol Genet. 2022. https://doi.org/10.1093/hmg/ddac233.

Article  PubMed  PubMed Central  Google Scholar 

Riboldi GM, Di Fonzo AB. GBA, Gaucher disease, and Parkinson’s disease: from genetic to clinic to new therapeutic approaches. Cells. 2019;8(4):364. https://doi.org/10.3390/cells8040364.

Huang J, Cheng Y, Li C, Shang H. Genetic heterogeneity on sleep disorders in Parkinson’s disease: a systematic review and meta-analysis. Transl Neurodegener. 2022;11(1):21. https://doi.org/10.1186/s40035-022-00294-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• Avenali M, Toffoli M, Mullin S, McNeil A, Hughes DA, Mehta A, et al. Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study. J Neurol Neurosurg Psychiatry. 2019;90(10):1091–7. https://doi.org/10.1136/jnnp-2019-320394This study analyses longitudinal changes of prodromal clinical symptoms in a group of GBA1 non-manifesting carriers.

Article  PubMed  Google Scholar 

Beavan M, McNeill A, Proukakis C, Hughes DA, Mehta A, Schapira AH. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. JAMA Neurol. 2015;72(2):201–8. https://doi.org/10.1001/jamaneurol.2014.2950.

Article  PubMed  PubMed Central  Google Scholar 

Krohn L, Ruskey JA, Rudakou U, Leveille E, Asayesh F, Hu MTM, et al. GBA variants in REM sleep behavior disorder: a multicenter study. Neurol. 2020;95(8):e1008–16. https://doi.org/10.1212/WNL.0000000000010042.

Article  CAS  Google Scholar 

Barber TR, Lawton M, Rolinski M, Evetts S, Baig F, Ruffmann C, et al. Prodromal Parkinsonism and neurodegenerative risk stratification in REM sleep behavior disorder. Sleep. 2017;40(8):zsx071. https://doi.org/10.1093/sleep/zsx071.

Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB, et al. Update of the MDS research criteria for prodromal Parkinson’s disease. Mov Disord. 2019;34(10):1464–70. https://doi.org/10.1002/mds.27802.

Article  PubMed  Google Scholar 

Horsager J, Andersen KB, Knudsen K, Skjaerbaek C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077–88. https://doi.org/10.1093/brain/awaa238.

Article  PubMed  Google Scholar 

McNeill A, Duran R, Proukakis C, Bras J, Hughes D, Mehta A, et al. Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord. 2012;27(4):526–32. https://doi.org/10.1002/mds.24945.

Article  PubMed  PubMed Central  Google Scholar 

Mullin S, Beavan M, Bestwick J, McNeill A, Proukakis C, Cox T, et al. Evolution and clustering of prodromal parkinsonian features in GBA1 carriers. Mov Disord. 2019;34(9):1365–73. https://doi.org/10.1002/mds.27775.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moran EE, Bressman SB, Ortega RA, Raymond D, Nichols WC, Palmese CA, et al. Cognitive functioning of glucocerebrosidase (GBA) non-manifesting carriers. Front Neurol. 2021;12:635958. https://doi.org/10.3389/fneur.2021.635958.

Article  PubMed  PubMed Central  Google Scholar 

Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, et al. Biochemical markers for severity and risk in GBA and LRRK2 Parkinson’s disease. J Neurol. 2021;268(4):1517–25. https://doi.org/10.1007/s00415-020-10325-4.

Article  CAS  PubMed  Google Scholar 

Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, et al. Mutations in GBA and LRRK2 are not associated with increased inflammatory markers. J Parkinsons Dis. 2021;11(3):1285–96. https://doi.org/10.3233/JPD-212624.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galper J, Balwani M, Fahn S, Waters C, Krohn L, Gan-Or Z, et al. Cytokines and Gaucher biomarkers in glucocerebrosidase carriers with and without Parkinson disease. Mov Disord. 2021;36(6):1451–5. https://doi.org/10.1002/mds.28525.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Glinka T, et al. Glucocerebrosidase activity is not associated with Parkinson’s disease risk or severity. Mov Disord. 2022;37(1):190–5. https://doi.org/10.1002/mds.28792.

Article  CAS  PubMed  Google Scholar 

Moran EE, Wang C, Katz M, Ozelius L, Schwartz A, Pavlovic J, et al. Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers. Neurobiol Aging. 2017;58(239):e1–7. https://doi.org/10.1016/j.neurobiolaging.2017.06.010.

Article  CAS  Google Scholar 

Pachi I, Koros C, Simitsi AM, Papadimitriou D, Bougea A, Prentakis A, et al. Apathy: an underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Parkinsonism Relat Disord. 2021;91:1–8. https://doi.org/10.1016/j.parkreldis.2021.08.008.

Article  CAS  PubMed  Google Scholar 

Gatto EM, Etcheverry JL, Sanguinetti A, Cesarini M, Fernandez Escobar N, Drelichman G. Prodromal clinical markers of Parkinson disease in Gaucher disease individuals. Eur Neurol. 2016;76(1–2):19–21. https://doi.org/10.1159/000447510.

Article  CAS  PubMed  Google Scholar 

Pont-Sunyer C, Tolosa E, Caspell-Garcia C, Coffey C, Alcalay RN, Chan P, et al. The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: clinical and imaging Studies. Mov Disord. 2017;32(5):726–38. https://doi.org/10.1002/mds.26964.

Article  CAS  PubMed  Google Scholar 

• Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, et al. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson’s Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol. 2020;19(1):71–80. https://doi.org/10.1016/S1474-4422(19)30319-9This study reports the analysis of both clinical and imaging characteristics in a large group of non-manifesting carriers of GBA1 and LRRK2 variants.

Mirelman A, Bernad-Elazari H, Thaler A, Giladi-Yacobi E, Gurevich T, Gana-Weisz M, et al. Arm swing as a potential new prodromal marker of Parkinson’s disease. Mov Disord. 2016;31(10):1527–34. https://doi.org/10.1002/mds.26720.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirelman A, Gurevich T, Giladi N, Bar-Shira A, Orr-Urtreger A, Hausdorff JM. Gait alterations in healthy carriers of the LRRK2 G2019S mutation. Ann Neurol. 2011;69(1):193–7. https://doi.org/10.1002/ana.22165.

Article  PubMed  Google Scholar 

Sanchez-Rodriguez A, Tirnauca C, Salas-Gomez D, Fernandez-Gorgojo M, Martinez-Rodriguez I, Sierra M, et al. Sensor-based gait analysis in the premotor stage of LRRK2 G2019S-associated Parkinson’s disease. Parkinsonism Relat Disord. 2022;98:21–6. https://doi.org/10.1016/j.parkreldis.2022.03.020.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif